Irinotecan and Ifosfamide Combination is an Effective and Safe Option in Patients with Refractory Small Cell Lung Cancer: A Retr
![2: Standard PEI/VIP, TIP and GIP salvage chemotherapy (interval 21 days) | Download Scientific Diagram 2: Standard PEI/VIP, TIP and GIP salvage chemotherapy (interval 21 days) | Download Scientific Diagram](https://www.researchgate.net/publication/340681546/figure/tbl2/AS:887557550260224@1588621618389/2-Standard-PEI-VIP-TIP-and-GIP-salvage-chemotherapy-interval-21-days.png)
2: Standard PEI/VIP, TIP and GIP salvage chemotherapy (interval 21 days) | Download Scientific Diagram
![ASCO GU 2021: Paclitaxel, Ifosfamide & Cisplatin (TIP) as Second-Line Therapy for Germ Cell Tumors: Long-Term Follow-up and Expansion Cohort ASCO GU 2021: Paclitaxel, Ifosfamide & Cisplatin (TIP) as Second-Line Therapy for Germ Cell Tumors: Long-Term Follow-up and Expansion Cohort](https://www.urotoday.com/images/ASCO_GU_Gleeson.png)
ASCO GU 2021: Paclitaxel, Ifosfamide & Cisplatin (TIP) as Second-Line Therapy for Germ Cell Tumors: Long-Term Follow-up and Expansion Cohort
SmartPhrase: Development of an electronic health record system to promote chemotherapy and immunotherapy safety - Document - Gale OneFile: Health and Medicine
![Outpatient administration of paclitaxel, ifosfamide, and cisplatin (TIP) for germ cell tumor - Allison J Schepers, David C Smith, Rachel L McDevitt, 2023 Outpatient administration of paclitaxel, ifosfamide, and cisplatin (TIP) for germ cell tumor - Allison J Schepers, David C Smith, Rachel L McDevitt, 2023](https://journals.sagepub.com/cms/10.1177/10781552231165243/asset/images/large/10.1177_10781552231165243-fig1.jpeg)
Outpatient administration of paclitaxel, ifosfamide, and cisplatin (TIP) for germ cell tumor - Allison J Schepers, David C Smith, Rachel L McDevitt, 2023
![PDF) Treatment of Base of Tongue Cancer With Paclitaxel, Ifosfamide, and Cisplatinum Induction Chemotherapy Followed by Chemoradiotherapy | Carl Bogardus - Academia.edu PDF) Treatment of Base of Tongue Cancer With Paclitaxel, Ifosfamide, and Cisplatinum Induction Chemotherapy Followed by Chemoradiotherapy | Carl Bogardus - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/47721578/mini_magick20190205-17905-1topuup.png?1549438180)
PDF) Treatment of Base of Tongue Cancer With Paclitaxel, Ifosfamide, and Cisplatinum Induction Chemotherapy Followed by Chemoradiotherapy | Carl Bogardus - Academia.edu
![TIP chemotherapy regimen used in this case series compared to standard... | Download Scientific Diagram TIP chemotherapy regimen used in this case series compared to standard... | Download Scientific Diagram](https://www.researchgate.net/publication/336612087/figure/tbl1/AS:814983533314062@1571318624616/TIP-chemotherapy-regimen-used-in-this-case-series-compared-to-standard-BEP-regimen.png)
TIP chemotherapy regimen used in this case series compared to standard... | Download Scientific Diagram
![ASCO GU 2021: Paclitaxel, Ifosfamide & Cisplatin (TIP) as Second-Line Therapy for Germ Cell Tumors: Long-Term Follow-up and Expansion Cohort ASCO GU 2021: Paclitaxel, Ifosfamide & Cisplatin (TIP) as Second-Line Therapy for Germ Cell Tumors: Long-Term Follow-up and Expansion Cohort](https://www.urotoday.com/images/ASCO_GU_IPFSG_risk.png)
ASCO GU 2021: Paclitaxel, Ifosfamide & Cisplatin (TIP) as Second-Line Therapy for Germ Cell Tumors: Long-Term Follow-up and Expansion Cohort
![GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours | British Journal of Cancer GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6603865/MediaObjects/41416_2007_Article_BF6603865_Fig1_HTML.jpg)
GAMEC – a new intensive protocol for untreated poor prognosis and relapsed or refractory germ cell tumours | British Journal of Cancer
![First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial | British Journal of Cancer First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial | British Journal of Cancer](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6600999/MediaObjects/41416_2003_Article_BF6600999_Fig1_HTML.gif)
First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: a prospective trial | British Journal of Cancer
![A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial | British Journal of A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial | British Journal of](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.bjc.6602682/MediaObjects/41416_2005_Article_BF6602682_Fig1_HTML.gif)
A phase II trial of TIP (paclitaxel, ifosfamide and cisplatin) given as second-line (post-BEP) salvage chemotherapy for patients with metastatic germ cell cancer: a medical research council trial | British Journal of
![Current Oncology | Free Full-Text | The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey Current Oncology | Free Full-Text | The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey](https://pub.mdpi-res.com/curroncol/curroncol-30-00458/article_deploy/html/images/curroncol-30-00458-g001.png?1687858868)
Current Oncology | Free Full-Text | The Use of Salvage Chemotherapy for Patients with Relapsed Testicular Germ Cell Tumor (GCT) in Canada: A National Survey
![IJMS | Free Full-Text | Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets IJMS | Free Full-Text | Advances in Understanding of Penile Carcinogenesis: The Search for Actionable Targets](https://pub.mdpi-res.com/ijms/ijms-18-01777/article_deploy/html/images/ijms-18-01777-g002.png?1569499445)